Disease: Watson syndrome
- <em>NF1</em>-Driven Rhabdomyosarcoma Phenotypes: A Comparative Clinical and Molecular Study of <em>NF1</em>-Mutant Rhabdomyosarcoma and <em>NF1</em>-Associated Malignant Triton Tumor
- "Cornflake nevoid" lesions, mimicking choroidal lesions of neurofibromatosis 1, in the absence of neurofibromatosis 1: An imaging-based hypothesis
- A 23-year-female with plexiform neurofibroma type 1: a rare clinical image
- A Case of Neurofibromatosis 1 with Myelopathy Due to Intracanal Rib Head and Kyphoscoliosis in an Adult
- A Case of Small Intestinal GIST Associated with Neurofibromatosis Type 1
- A case report of giant malignant schwannoma of the sciatic nerve associated with neurofibromatosis-1: A CARE-compliant article
- A genetic study to understand more about the variability in appearance, number and growth of neurofibromas in people with neurofibromatosis type 1
- A Giant Scrotal Neurofibroma in a Child Masquerading as Filariasis: Uncommon Presentation of a Common Disease
- A global core outcome measurement set for snakebite clinical trials
- A new frameshift mutation in a patient with neurofibromatosis type I
- A Systematic Review on Visual-Processing Deficits in Neurofibromatosis Type 1: What Possible Impact on Learning to Read?
- Acquired myelinated retinal nerve fiber layer in a child with neurofibromatosis 1-related optic pathway glioma
- Analysis of clinical features and variants of NF1 gene in 12 patients with Neurofibromatosis type 1
- Analysis of NF1 gene variants in a Chinese pedigree and a sporadic patient with Neurofibromatosis type 1
- Autism spectrum disorder profiles in RASopathies: A systematic review
- Automatic Visual Acuity Loss Prediction in Children with Optic Pathway Gliomas using Magnetic Resonance Imaging
- Biallelic variants in Plexin B2 (<em>PLXNB2</em>) cause amelogenesis imperfecta, hearing loss and intellectual disability
- Bone ineral density, vitamin D and osseous metabolism indices in neurofibromatosis type 1: A systematic review and meta-analysis
- Bone mineral density, vitamin D and osseous metabolism indices in neurofibromatosis type 1: A systematic review and meta-analysis
- Brain injury drives optic glioma formation through neuron-glia signaling
- Breast density in NF1 women: a retrospective study
- Burnout Syndrome Among Critical Care Health Providers in Saudi Arabia
- CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond
- Challenges in treating children with optic pathway gliomas: an 18-year experience from a middle-income country
- Clinical characteristics of epileptic seizure in neurofibromatosis type 1 in 15 cases
- Congenital Pseudoarthrosis of Tibia With Anterolateral Bowing Treated With Ilizarov Ring Fixator: A Case Report
- Correction of cervical kyphoscoliosis, bisected spinal cord, and vertebral artery to epidural vein fistula in neurofibromatosis type 1
- Cutaneous toxicities of mitogen-activated protein kinase inhibitors in children and young adults with neurofibromatosis-1
- Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine
- Dermatofibrosarcoma protuberans: Case series in a tropical setting and review of literature
- Design and rationale of the Post-Intensive Care Syndrome - paediatrics (PICS-p) Longitudinal Cohort Study
- DRI Triton SS-OCT applied to detect choroidal nodules in paediatric patients affected by NF1
- Drosophila Contributions towards Understanding Neurofibromatosis 1
- Dural ectasia with cauda equina syndrome, a rare case report
- Econazole selectively induces cell death in NF1-homozygous mutant tumor cells
- Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1
- Endocrine and non-endocrine causes of fatigue in adults with Neurofibromatosis type 1
- Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019
- Frequency of Acne and Acne Scars in Patients with Neurofibromatosis 1
- FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells
- Functional and Radiological Outcomes of All-Posterior Surgical Correction of Dystrophic Curves in Patients with Neurofibromatosis Type 1
- Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance
- Gene therapy strategies and prospects for neurofibromatosis type 1
- Genetic Testing for Supravalvar Aortic Stenosis: What to Do When It Is Not Williams Syndrome
- Genetically confirmed coexistence of neurofibromatosis type 1 and Cherubism in a pediatric patient
- Giant gluteal and vesical plexiform neurofibromas in a patient with neurofibromatosis type 1: a case report
- Healthcare cost and utilization for chimeric antigen receptor (CAR) T-cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance claims database analysis
- High-Grade Astrocytoma with Piloid Features: A Dual Institutional Review of Imaging Findings of a Novel Entity
- High-threshold and low-overhead fault-tolerant quantum memory
- Highly Active Relapsing-Remitting Multiple Sclerosis with Neurofibromatosis Type 1: Radiological Aspects and Therapeutic Challenges - Case Report
- Histologic correlates of "Choroidal abnormalities" in Neurofibromatosis type 1 (NF1)
- HSR24-150: Real-World Treatment Patterns of Selumetinib Among Patients With Neurofibromatosis Type I and Plexiform Neurofibroma in the United States
- Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes
- Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
- Impact of neurofibromatosis type 1 on quality of life using the Skindex-29 questionnaire quality of life in NF1
- Impact of neurofibromatosis type 1 with plexiform neurofibromas on the health-related quality of life and work productivity of adult patients and caregivers in the UK: a cross-sectional survey
- In vitro data suggest a role for PMS2 Kozak sequence mutations in Lynch Syndrome risk
- Influence of Eat, Sleep, and Console on Infants Pharmacologically Treated for Opioid Withdrawal: A Post Hoc Subgroup Analysis of the ESC-NOW Randomized Clinical Trial
- Integrin α<sub>5</sub>β<sub>1</sub> contributes to cell fusion and inflammation mediated by SARS-CoV-2 spike via RGD-independent interaction
- International Consensus Criteria for Pediatric Sepsis and Septic Shock
- Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
- Late-Onset Masseteric Metastasis of Malignant Melanoma in a Patient With Neurofibromatosis and Lipomatosis: A Diagnostic Challenge and Case Report
- Living with… neurofibromatosis type 1
- Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study
- Multidisciplinary team for patients with neurocutaneous syndromes: The little discussed importance of dentistry
- Multimodal Imaging of Choroidal Nodules in Neurofibromatosis Type I
- Multiple Gastrointestinal Stromal Tumors, Malignant Peripheral Nerve Sheath Tumor and Atypical Neurofibromatous Neoplasm With Uncertain Biologic Potential Developing in A Single Patient With Neurofibromatosis Type 1 Syndrome
- Neurofibromatosis Type 1 Vasculopathy Presenting as Branch Retinal Vein Occlusion: Case Report and Review of the Literature
- Neurofibromin 1 controls metabolic balance and Notch-dependent quiescence of murine juvenile myogenic progenitors
- Olfactory bulb anomalies in KBG syndrome mouse model and patients
- Outcomes that need to be assessed in clinical trials for cutaneous neurofibromas in people with neurofibromatosis type 1
- Overuse Injuries, Overtraining, and Burnout in Young Athletes
- Patient characteristics, treatment patterns, healthcare resource utilization, and costs among patients diagnosed with neurofibromatosis type 1 with and without plexiform neurofibromas in Japan
- Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1
- Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury
- Prevalence of lung cysts in adolescents and adults with a germline <em>DICER1</em> pathogenic/likely pathogenic variant: a report from the National Institutes of Health and International Pleuropulmonary Blastoma/<em>DICER1</em> Reg
- Quality of life in patients with neurofibromatosis type 1: a nationwide database study in Japan from 2015 to 2019
- Quantifying the clinical and economic burden of desquamating dermatological conditions: Implications for a supraregional burns centre
- Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma
- Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials
- Resiliency outcomes after participation in an asynchronous web-based platform for adults with neurofibromatosis: The NF-Web study
- RNA therapeutics for metabolic disorders
- Robotic resection for splenic artery aneurysm associated with neurofibromatosis type 1: a case report
- Safety, pharmacokinetics and efficacy of selumetinib in Chinese adult and paediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas: The primary analysis of a phase 1 open-label study
- Schwann cells modulate nociception in neurofibromatosis 1
- Secondary (additional) findings from the 100,000 Genomes Project: disease manifestation, healthcare outcomes and costs of disclosure
- Spontaneous radiological regression of optic nerve glioma in a child: A dilemma
- Survival outcomes of malignant peripheral nerve sheath tumors (MPNSTs) with and without neurofibromatosis type I (NF1): a meta-analysis
- The Association of Quality of Life with Psychosocial Factors in Adolescents with Tourette Syndrome
- The Effect of a Tobacco Use Reduction Program on the Prevalence of Smoking and Tobacco Use and Quitting Behavior Among People Living With HIV/AIDS in Michigan
- The management of neurofibromatosis type 1 (NF1) in children and adolescents
- The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands
- The Rare Presence of Two Genetic Disorders (Neurofibromatosis 1 and X-Linked Recessive Ichthyosis) in a Single Patient
- The role of scoliosis on the comorbidity and demographics of neurofibromatosis type 1 patients: A retrospective analysis of the National Inpatient Sample database
- Tibial Dysplasia in Neurofibromatosis-1: A Rare Case Report and Review of Literature
- Transcranial Direct Current Stimulation in neurogenetic syndromes: new treatment perspectives for Down syndrome?
- Understanding the patient's experience of coeliac disease diagnosis: a qualitative interview study
- Unusual Presentation of a Granulocytic Sarcoma
- Whole-body <sup>18</sup>F-FDG-PET/MRI as a screening tool for the detection of malignant transformation in individuals with Neurofibromatosis type 1
- Whole-exome sequencing revealed a likely pathogenic variant in NF1 causing neurofibromatosis type I and Arrhythmogenic Cardiomyopathy